Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
River Eletec
6666
Heartseed
219A
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 27.66%68.16B | 17.15%207.97B | -34.67%84.43B | 401.93%45.68B | 740.56%24.48B | 47.20%53.39B | 9.67%177.52B | 57.46%129.24B | 10.40%9.1B | -82.04%2.91B |
Net profit before non-cash adjustment | 66.50%41.8B | -46.75%59.57B | -686.16%-16.74B | 13.66%27.32B | -13.98%23.87B | -56.13%25.11B | -7.02%111.87B | 1,586.98%2.86B | -38.84%24.04B | -31.08%27.75B |
Total adjustment of non-cash items | -10.07%23.98B | 63.24%181.11B | 71.96%88.26B | 6.28%30.83B | 20.95%35.36B | 1,829.59%26.67B | -13.88%110.94B | -7.27%51.32B | 11.17%29.01B | 17.01%29.24B |
-Depreciation and amortization | 4.92%32.74B | 2.23%129.19B | 5.08%32.37B | 3.73%33.27B | 0.77%32.35B | -0.61%31.21B | 4.99%126.38B | 1.25%30.81B | 5.39%32.07B | 8.01%32.1B |
-Reversal of impairment losses recognized in profit and loss | 65.23%765M | 513.48%36.78B | 632.68%36.17B | 32.56%57M | -12.39%99M | -48.78%463M | -78.15%6B | -81.81%4.94B | 43.33%43M | -58.46%113M |
-Share of associates | 10.82%-3.28B | -19.63%-8.85B | -98.36%79M | 25.34%-2B | 39.73%-3.26B | 11.16%-3.68B | 61.75%-7.4B | 238.54%4.82B | 35.52%-2.67B | 27.45%-5.4B |
-Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | ---25.07B | --0 | --0 | --0 |
-Other non-cash items | -371.53%-6.24B | 117.28%23.98B | 82.49%19.64B | -15.17%-501M | 154.56%6.17B | 22.66%-1.32B | 3,017.80%11.04B | 756.77%10.76B | -94.20%-435M | -0.62%2.42B |
Changes in working capital | 46.90%2.37B | 27.80%-32.71B | -82.80%12.91B | 71.61%-12.47B | 35.73%-34.76B | 107.23%1.61B | 48.10%-45.3B | 178.76%75.06B | 23.11%-43.94B | -10.28%-54.08B |
-Change in receivables | -40.47%18.7B | -1,608.96%-51.38B | -125.90%-18.3B | 52.94%-13.13B | -10.49%-51.36B | 341.39%31.41B | 110.05%3.41B | 164.58%70.66B | 52.04%-27.89B | -77.91%-46.49B |
-Change in inventory | 29.23%-15.73B | 168.02%22.86B | 31.96%33.13B | -101.48%-6.14B | 253.60%18.1B | 49.36%-22.22B | 55.75%-33.61B | 436.99%25.11B | 78.52%-3.05B | 59.97%-11.78B |
-Change in payables | 108.58%628M | 71.09%-3.1B | 94.90%-1.01B | 171.35%6.98B | -140.51%-1.75B | -150.18%-7.32B | -137.79%-10.74B | -338.08%-19.86B | -153.88%-9.78B | -44.26%4.32B |
-Changes in other current assets | -387.30%-1.23B | 75.20%-1.08B | -6.97%-906M | 94.27%-185M | 300.00%262M | -64.71%-252M | 25.72%-4.36B | -25.85%-847M | -8.87%-3.23B | 89.38%-131M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 3.71%4.25B | 6.15%18.16B | 44.24%4.62B | 0.15%8.46B | -47.45%980M | 14.10%4.1B | -2.59%17.11B | -14.92%3.21B | 24.38%8.45B | -47.77%1.87B |
Interest paid (cash flow from operating activities) | -34.59%-4.35B | -56.11%-16.75B | -25.82%-5.05B | -58.61%-4.04B | -55.17%-4.42B | -145.82%-3.24B | -116.16%-10.73B | -225.00%-4.02B | -115.83%-2.55B | -79.45%-2.85B |
Interest received (cash flow from operating activities) | 6.13%1.33B | 67.85%6.1B | 51.32%2.18B | 29.28%1.28B | 88.12%1.39B | 167.45%1.26B | 142.24%3.64B | 229.06%1.44B | 196.40%987M | 114.78%741M |
Tax refund paid | -10.17%-12.31B | 29.57%-29.81B | -25.05%-6.74B | 24.37%-11.43B | 91.68%-468M | 31.04%-11.17B | -12.33%-42.32B | 34.60%-5.39B | -24.66%-15.11B | 18.38%-5.62B |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | 28.74%57.08B | 27.87%185.68B | -36.18%79.44B | 4,464.80%39.94B | 844.39%21.97B | 94.31%44.34B | 5.01%145.21B | 62.06%124.47B | -57.63%875M | -125.32%-2.95B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -38.26%-35.95B | -33.62%-131.73B | -31.51%-41.79B | -30.28%-29.54B | -59.25%-34.4B | -15.37%-26B | -10.88%-98.59B | -19.92%-31.78B | -9.04%-22.67B | -8.63%-21.6B |
Net business purchase and sale | --0 | ---6.46B | --0 | --0 | --0 | ---6.46B | --0 | --0 | ---- | ---- |
Net investment product transactions | -2.41%2.18B | 492.52%19.64B | 2,792.79%6.02B | 151.91%4.28B | 412.03%7.11B | 11,090.00%2.24B | -91.12%3.32B | 229.19%208M | -23.30%1.7B | -95.77%1.39B |
Net changes in other investments | -73.27%-2.74B | 67.08%-2.45B | 235.25%1.69B | -225.86%-3.62B | 189.14%1.05B | 59.63%-1.58B | -876.54%-7.45B | -404.44%-1.25B | -169.03%-1.11B | 6.21%-1.18B |
Investing cash flow | -14.79%-36.5B | -17.79%-121B | -3.85%-34.08B | -30.75%-28.87B | -22.67%-26.24B | -20.32%-31.8B | -79.69%-102.72B | -20.86%-32.82B | -10.53%-22.08B | -283.69%-21.39B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 90.67%-974M | -278.31%-53.35B | 7.92%-73.28B | -27.49%29.11B | -54.90%1.25B | -146.26%-10.44B | 78.86%-14.1B | -196.02%-79.58B | 21.99%40.14B | 105.09%2.78B |
Increase or decrease of lease financing | -7.22%-3.05B | 0.85%-11.61B | -4.20%-2.9B | 5.87%-2.92B | -2.05%-2.94B | 3.17%-2.84B | -0.57%-11.7B | 6.16%-2.79B | -6.30%-3.1B | -1.16%-2.88B |
Cash dividends paid | -0.30%-13.85B | -5.89%-28.83B | 2.82%-69M | -0.01%-14.35B | 1.95%-603M | -13.25%-13.81B | -35.98%-27.23B | -18.33%-71M | -12.55%-14.35B | -63.56%-615M |
Cash dividends for minorities | -78.72%-2.83B | -20.89%-5.17B | -81.89%-231M | -15.49%-701M | -25.75%-2.65B | -10.61%-1.58B | -35.71%-4.28B | -3.25%-127M | -10.56%-607M | -78.88%-2.11B |
Net other fund-raising expenses | 81.03%-48M | 40,359.15%28.58B | 99,600.00%28.86B | 40.00%-9M | -800.00%-9M | -873.08%-253M | -2,266.67%-71M | -2,800.00%-29M | ---15M | 0.00%-1M |
Financing cash flow | 28.26%-20.75B | -22.64%-70.37B | 42.34%-47.62B | -49.59%11.13B | -74.96%-4.95B | -584.24%-28.92B | 43.48%-57.38B | -174.97%-82.59B | 32.24%22.07B | 95.19%-2.83B |
Net cash flow | ||||||||||
Beginning cash position | 5.31%235.89B | -2.76%224B | 6.89%229.39B | -6.08%212.59B | -12.53%216.54B | -2.76%224B | -2.54%230.36B | 6.16%214.61B | 13.88%226.35B | 5.81%247.57B |
Current changes in cash | 98.95%-172M | 61.80%-5.69B | -125.04%-2.27B | 2,477.82%22.2B | 66.04%-9.23B | -794.19%-16.38B | 27.01%-14.89B | -53.79%9.07B | 170.29%861M | 23.65%-27.18B |
Effect of exchange rate changes | 37.19%12.25B | 106.11%17.58B | 2,647.65%8.77B | 57.20%-5.39B | -11.46%5.28B | -39.86%8.93B | -40.77%8.53B | -96.28%319M | -372.47%-12.6B | 1,439.79%5.96B |
End cash Position | 14.51%247.97B | 5.31%235.89B | 5.31%235.89B | 6.89%229.39B | -6.08%212.59B | -12.53%216.54B | -2.76%224B | -2.76%224B | 6.16%214.61B | 13.88%226.35B |
Free cash flow | 1.25%17.55B | 19.89%51.55B | -58.30%37.5B | 144.57%9.79B | 47.11%-13.08B | 8,089.86%17.34B | -6.71%43B | 83.56%89.92B | -13.27%-21.97B | -184.53%-24.73B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |